Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
electroCore
ECOR
electroCore
Slow VA Adoption Will Hinder Operations Yet Will Reveal Opportunity
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 4 Analysts
Published
14 Aug 25
Updated
14 Aug 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
US$12.00
53.2% undervalued
intrinsic discount
14 Aug
US$5.62
Loading
1Y
-5.8%
7D
7.4%
Author's Valuation
US$12.0
53.2% undervalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
US$12.0
53.2% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-55m
78m
2016
2018
2020
2022
2024
2025
2026
2028
Revenue US$78.0m
Earnings US$9.7m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
24.45%
Medical Equipment revenue growth rate
0.44%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
7.71%
Calculation
US$9.71m
Earnings '28
x
19.07x
PE Ratio '28
=
US$185.15m
Market Cap '28
US$185.15m
Market Cap '28
/
12.34m
No. shares '28
=
US$15.00
Share Price '28
US$15.00
Share Price '28
Discounted to 2025 @ 7.73% p.a.
=
US$12.00
Fair Value '25
